Deutsche Bank Aktiengesellschaft Begins Coverage on Autolus Therapeutics (NASDAQ:AUTL)

Deutsche Bank Aktiengesellschaft started coverage on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research report released on Thursday, MarketBeat Ratings reports. The firm issued a buy rating and a $10.00 price target on the stock. Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC […]

Leave a Reply

Your email address will not be published.

Previous post 3 takeaways from the Chicago Cubs at the GM meetings, including what rotation will look like after Marcus Stroman’s opt-out
Next post Unilever (NYSE:UL) Rating Increased to Overweight at Barclays